Pharmaceutical Products

Share us

1030377-33-3;MK-4305;Suvorexant; MK 4305

1030377-33-3;MK-4305;Suvorexant; MK 4305

Description

Suvorexant (MK-4305) is a potent, selective, and orally bioavailable antagonist of OX1R and OX2R currently under clinical investigation as a novel therapy for insomnia.Orexins/hypocretins are key neuropeptides responsible for regulating central arousal and reward circuits. Two receptors respond to orexin signaling, orexin 1 receptor (OX1R) and orexin 2 receptor (OX2R) with partially overlapping nervous system distributions. Genetic studies suggest orexin receptor antagonists could be therapeutic for insomnia and other disorders with disruptions of sleep and wake. Suvorexant (MK-4305) was found.
http://www.chemscene.com/MK-4305.html

1030377-33-3, MK-4305;Suvorexant; MK 4305,

Read More

Previous

1268524-70-4;(+)-JQ-1...

Previous

842133-18-0;Canagliflozin;JNJ 24831754ZAE; JNJ 284...

ChemScene, LLC

ChemScene Pharmaceutical chemical

Address: 11 Deer Park Drive, Suite 102A, Monmouth Junction, NJ 08852,
jersey, new jersey
United States, 07097

Tel: 732-484-9848
Fax:

H5响应式定制设计
26种语言,SEO营销型网站


H5/响应式/营销型企业网站; 26种语言扩展;
覆盖: 英文、法语、德语、西班牙语、葡萄牙语、俄语、阿拉伯语、波斯语、日语、韩语
了解更多